Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference24 articles.
1. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902;van der Hage;J Clin Oncol,2001
2. Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer;Singletary;Am J Surg,2001
3. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel;von Minckwitz;J Clin Oncol,1999
4. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2003
5. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study;Scientific Reports;2024-05-23
2. Prognosis and Influencing Factors of ER-positive, HER2-low Patients with Residual Diseases after Neoadjuvant Chemotherapy: A Retrospective Study;2023-07-24
3. EVALUATION OF KI-67 AS INDEPENDENT RISK FACTOR AND ITS ROLE IN THE INCIDENCE OF LOCAL RECURRENCE/DISTANT METASTASIS IN LUMINAL A AND LUMINAL B (HER2 NEGATIVE) BREAST CANCER: A RETROSPECTIVE ANALYSIS FROM A SINGLE CANCER CENTER;WORLD CANCER RES J;2023
4. Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy;Frontiers in Oncology;2022-12-01
5. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy;Clinical Breast Cancer;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3